Our results showed a significant loss of CAPS1 expression in HCC tissues and HCC cells, and a close correlation of reduced CAPS1 expression in the tumor tissues with poor survival and high recurrence rates in HCC patients. This evidence concerns the gene CAPS and hepatocellular carcinoma.